ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ASTH vs NSP // 10Y YIELD & FRED MACRO BETA

Astrana Health Inc. (NASDAQ) VS. Insperity Inc. (NYSE) • 15-METRIC TALLY: ASTH 8 — NSP 1
■ METRIC PARITY
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ASTH VS. NSP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ASTH NSP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 13.20% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 4.60% -8.90% +13.50 ASTH /roic <GO>
EV/EBITDA & P/E Valuation 27.3x — — TIE /valuation <GO>
Free Cash Flow Yield 5.75% -17.48% +23.23 ASTH /fcf-yield <GO>
Operating Margin 2.50% -0.10% +2.60 ASTH /operating-margins <GO>
Net Profit Margin 0.80% -0.10% +0.90 ASTH /net-margins <GO>
Revenue Growth (YoY) 56.40% 3.50% +52.90 ASTH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.43% 5.09% -4.66 NSP /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.54 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 1/9 +5.00 ASTH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 46.3 +0.45 ASTH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 63.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.82B $1.77B $48.5M ASTH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ASTH REV NSP REV ASTH GROSS % NSP GROSS % ASTH FCF NSP FCF
FY 2025 $3.18B $6.81B — 13.2% $104.5M -$309.0M
FY 2024 $2.03B $6.58B — 16.0% $44.2M $482.0M
FY 2023 $1.39B $6.49B — — $68.2M $198.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ASTH // BETA —
NSP // BETA —